Trial Profile
A phase I/II single-centre double-blinded randomized study of the safety and tolerability of TMC120 [dapivirine] vaginal microbicide gel (TMC120 Gel-002) vs. HEC-based universal placebo gel in healthy HIV-negative women
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 14 Oct 2006 New trial record.